422 related articles for article (PubMed ID: 29697362)
1. An integrated clinical and genomic information system for cancer precision medicine.
Jang Y; Choi T; Kim J; Park J; Seo J; Kim S; Kwon Y; Lee S; Lee S
BMC Med Genomics; 2018 Apr; 11(Suppl 2):34. PubMed ID: 29697362
[TBL] [Abstract][Full Text] [Related]
2. A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
[TBL] [Abstract][Full Text] [Related]
5. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
[TBL] [Abstract][Full Text] [Related]
6. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
Maggi E; Montagna C
Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
[TBL] [Abstract][Full Text] [Related]
7. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
8. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
9. Physician interpretation of genomic test results and treatment selection.
Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
[TBL] [Abstract][Full Text] [Related]
10. Genomics-Enabled Precision Medicine for Cancer.
Roos A; Byron SA
Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
[TBL] [Abstract][Full Text] [Related]
11. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
12. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
Surrey LF; Luo M; Chang F; Li MM
Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
[TBL] [Abstract][Full Text] [Related]
13. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
14. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
15. Rate of change in investigational treatment options: An analysis of reports from a large precision oncology decision support effort.
Araya A; Zeng J; Johnson A; Shufean MA; Rodon J; Meric-Bernstam F; Bernstam EV
Int J Med Inform; 2020 Nov; 143():104261. PubMed ID: 32889387
[TBL] [Abstract][Full Text] [Related]
16. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
Dumbrava EI; Meric-Bernstam F
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
[TBL] [Abstract][Full Text] [Related]
17. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
[TBL] [Abstract][Full Text] [Related]
18. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
19. Tri©DB: an integrated platform of knowledgebase and reporting system for cancer precision medicine.
Jiang W; Wang PY; Zhou Q; Lin QT; Yao Y; Huang X; Tan X; Yang S; Ye W; Yang Y; Bao YJ
J Transl Med; 2023 Dec; 21(1):885. PubMed ID: 38057859
[TBL] [Abstract][Full Text] [Related]
20. Precision Oncology: Who, How, What, When, and When Not?
Schwartzberg L; Kim ES; Liu D; Schrag D
Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
